Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes
- PMID: 1879940
- PMCID: PMC258162
- DOI: 10.1128/iai.59.9.3267-3272.1991
Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes
Abstract
The majority of strains of Actinobacillus actinomycetemcomitans isolated from patients with periodontal diseases secrete a leukotoxin that destroys human myeloid cells within minutes but has no effect on viability of peripheral blood lymphocytes in culture for 1.5 h. However, since this organism persists in the gingival crevice and thus may continuously release toxin over extended periods of time, we assessed the viability of T cells cultured with leukotoxin (0 to 250 ng/ml) for up to 2 days. Although the total numbers of cells recovered from cultures with or without leukotoxin were equivalent, leukotoxin killed up to 70% of the T cells in a time- and concentration-dependent manner. Cell death was associated with uptake of propidium iodide, release of 51Cr from the cytoplasm, and morphological evidence of damage to the plasma membrane and apoptosis. Leukotoxin also induced increased cleavage of chromosomal DNA into nucleosome-sized fragments, suggesting activation of an endogenous nuclease in the T cells. These data suggest that leukotoxin kills T cells by pathways resembling necrosis and programmed cell death. Leukotoxin-induced lymphotoxicity may represent a critical mechanism by which A. actinomycetemcomitans suppresses the host local immune response and contributes to the pathogenesis of diseases involving this microorganisms.
Similar articles
-
Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells.J Immunol. 1991 Nov 15;147(10):3587-94. J Immunol. 1991. PMID: 1940358
-
Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.Oral Microbiol Immunol. 2002 Jun;17(3):143-9. doi: 10.1034/j.1399-302x.2002.170302.x. Oral Microbiol Immunol. 2002. PMID: 12030965
-
Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin.Infect Immun. 1988 Jan;56(1):122-7. doi: 10.1128/iai.56.1.122-127.1988. Infect Immun. 1988. PMID: 3335399 Free PMC article.
-
Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.J Dent Res. 2010 Jun;89(6):561-70. doi: 10.1177/0022034510363682. Epub 2010 Mar 3. J Dent Res. 2010. PMID: 20200418 Free PMC article. Review.
-
Beyond the specific plaque hypothesis: are highly leukotoxic strains of Actinobacillus actinomycetemcomitans a paradigm for periodontal pathogenesis?Crit Rev Oral Biol Med. 2001;12(2):116-24. doi: 10.1177/10454411010120020201. Crit Rev Oral Biol Med. 2001. PMID: 11345522 Review.
Cited by
-
Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering.Nutr Metab (Lond). 2012 Apr 17;9(1):32. doi: 10.1186/1743-7075-9-32. Nutr Metab (Lond). 2012. PMID: 22510431 Free PMC article.
-
Caspase-2 and caspase-7 are involved in cytolethal distending toxin-induced apoptosis in Jurkat and MOLT-4 T-cell lines.Infect Immun. 2004 Feb;72(2):871-9. doi: 10.1128/IAI.72.2.871-879.2004. Infect Immun. 2004. PMID: 14742531 Free PMC article.
-
Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.Toxins (Basel). 2011 Mar;3(3):242-59. doi: 10.3390/toxins3030242. Epub 2011 Mar 18. Toxins (Basel). 2011. PMID: 22069708 Free PMC article. Review.
-
Aggregatibacter actinomycetemcomitans LtxA Hijacks Endocytic Trafficking Pathways in Human Lymphocytes.Pathogens. 2020 Jan 21;9(2):74. doi: 10.3390/pathogens9020074. Pathogens. 2020. PMID: 31973183 Free PMC article.
-
Aggregatibacter (Actinobacillus) actimycetemcomitans leukotoxin and human periodontitis - A historic review with emphasis on JP2.Kaohsiung J Med Sci. 2018 Apr;34(4):186-193. doi: 10.1016/j.kjms.2018.01.014. Epub 2018 Feb 17. Kaohsiung J Med Sci. 2018. PMID: 29655406 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources